Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007341
Chunk: 14

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 14
---
 notes thereto and other
financial information incorporated by reference into this prospectus.

| (£ in thousands)          |     | As of December 31, 2024 |       |
|:--------------------------|:----|:------------------------|------:|
| Cash and cash equivalents |     |                         | 1,669 |
| Long-term debt            |     |                         |   118 |
| Total equity              |     |                         | 8,322 |
| Total capitalization      |     |                         | 8,440 |

The table above does not include, as of December
31, 2024:

| · | 328,823,388 Ordinary Shares issuable upon the exercise of stock options outstanding under our equity incentive plans at a weighted-average 
 exercise price of £0.005 per share;                                                                                                        |

| · | 99 Ordinary Shares issuable upon the exercise of stock options in connection with the acquisition of Dara (as defined below) at a 
 weighted average exercise price of $877.13 per share; and                                                                         |

| · | warrants, including pre-funded warrants, exercisable for 770,026 Depositary Shares (representing 7,700,260,000 Ordinary Shares), at 
 a weighted average exercise price of $38.42 per Depositary Share.                                                                   |

| 14 |

<div align='center'>DESCRIPTION OF OFFERED SECURITIES AND SHARE CAPITAL</div>

The following describes our issued share capital, summarizes the material provisions of our Articles of Association and highlights certain differences in corporate law in the United Kingdom and the United State. This description of our share capital and summary of our Articles of Association is not complete, and is qualified by reference to our Articles of Association. You should read our Articles of Association, which are filed as an exhibit to the registration statement of which this prospectus forms a part, for the provisions that are important to you.

General

We are a public limited company
organized under the laws of England and Wales under registered number 09216368. Our registered office is 1 Caspian Point, Caspian Way,
Cardiff, CF10 4DQ, United Kingdom. The principal legislation under which we operate and our shares are issued is the United Kingdom Companies
Act of 2006, or the Companies Act.

Issued Share Capital

Our issued share capital as
of December 31, 2024 and April 1, 2025 was 6,685,918,822 Ordinary Shares and